Search

Becton Dickinson and Co

Open

SectorGezondheidszorg

183.61 1.86

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

179.97

Max

182.1

Belangrijke statistieken

By Trading Economics

Inkomsten

759M

449M

Verkoop

269M

5B

K/W

Sectorgemiddelde

31.645

56.432

EPS

3.23

Dividendrendement

2.36

Winstmarge

9.011

Werknemers

72,000

EBITDA

-23M

686M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+6.97% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

2.36%

2.27%

Volgende Winsten

5 nov 2026

Volgende dividenddatum

30 sep 2026

Volgende Ex Dividend datum

7 dec 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

4.2B

50B

Vorige openingsprijs

181.75

Vorige sluitingsprijs

183.61

Nieuwssentiment

By Acuity

52%

48%

247 / 339 Rangschikking in Healthcare

Becton Dickinson and Co Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 sep 2026, 19:52 UTC

Becton Dickinson and Co is trading modestly higher amid a broader market divergence from the recent trend of higher daily closes since Thursday.

17 sep 2026, 20:07 UTC

Becton Dickinson and Co shares fell modestly on Thursday, closing below the 20-day moving average and near the lower end of their one-month range.

16 sep 2026, 19:04 UTC

Becton Dickinson and Co shares fell sharply, reversing a trend of higher daily closes observed since Tuesday's close.

15 sep 2026, 20:13 UTC

Becton Dickinson and Co shares are lower in after-market hours amid broader market caution following a decline in the manufacturing index and inflation concerns.

14 sep 2026, 22:31 UTC

Becton Dickinson and Co is trading higher in after-market hours, continuing a trend from the past three sessions amid broader market dynamics and inflation concerns.

11 sep 2026, 20:31 UTC

Becton Dickinson and Co shares are lower in after-market hours amid broader market weakness and speculation over potential Federal Reserve interest rate hikes.

10 sep 2026, 20:01 UTC

Becton Dickinson shares are lower today, reflecting ongoing weakness amid a broader market backdrop following the European Central Bank's interest rate hike.

9 sep 2026, 20:07 UTC

Becton Dickinson and Co's shares are higher today amid routine trading. No specific news has been identified to explain the movement.

8 sep 2026, 23:41 UTC

Becton Dickinson and Co shares rose in after-market trading, recovering from earlier losses. The price remains below its 20-day moving average.

4 sep 2026, 20:08 UTC

Becton Dickinson is lower today amid broader market declines following a strong jobs report that has pressured risk assets. No specific company news was identified.

2 sep 2026, 20:08 UTC

Becton Dickinson shares are higher today, continuing a trend of slight gains since Tuesday's close, despite a minor pullback during the session.

1 sep 2026, 23:56 UTC

Becton Dickinson and Co shares rose in after-market trading, reflecting a position above its 20-day moving average and near the top of its one-month range.

31 aug 2026, 21:03 UTC

Becton Dickinson and Co shares are higher in after-market hours, maintaining a strong upward trajectory above the 20-day moving average. No specific news was identified.

28 aug 2026, 20:08 UTC

Becton Dickinson shares are higher, reflecting gains since Thursday. The stock earlier reached a session high before pulling back slightly.

27 aug 2026, 22:26 UTC

Becton Dickinson and Co shares are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

26 aug 2026, 20:08 UTC

Becton Dickinson shares are higher today amid mixed market performance and recent inflation data, with no specific news identified to explain the movement.

25 aug 2026, 23:36 UTC

Becton Dickinson shares are higher in after-market trading, positioned above its 20-day moving average and near the upper end of its one-month range.

24 aug 2026, 19:46 UTC

Becton Dickinson is trading lower, influenced by rising oil prices and geopolitical tensions. The stock reached a session high earlier but has since declined.

21 aug 2026, 23:01 UTC

Becton Dickinson shares are lower in after-market trading, following unusual activity despite a strong one-month gain and trading above the 20-day moving average.

20 aug 2026, 20:06 UTC

Becton Dickinson and Co is trading higher, maintaining an upward trajectory since Wednesday's close, despite some intraday volatility. No specific news was identified.

19 aug 2026, 21:01 UTC

Becton Dickinson and Co shares are lower in after-market trading, showing unusual weakness despite remaining above the 20-day moving average. No specific news was identified.

18 aug 2026, 19:46 UTC

Becton Dickinson and Co shares are lower today, breaking a trend of higher daily closes amid rising Treasury yields and inflation concerns.

17 aug 2026, 23:01 UTC

News

Becton Dickinson appoints Gary Sorsher as executive vice president and chief quality officer, effective September 8. Shares are higher in after-market trading.

14 aug 2026, 19:36 UTC

Becton Dickinson is trading higher today, despite a reported decline in retail sales for July that raised concerns about consumer demand.

13 aug 2026, 22:01 UTC

Becton Dickinson shares are lower in after-market hours, continuing a decline from Thursday's close amid overall weakness in after-hours trading.

12 aug 2026, 23:46 UTC

Event

Becton Dickinson announced successful enrollment completion in the PREVENT clinical trial for Phasix™ Mesh. Shares remain roughly flat in after-market trading.

11 aug 2026, 22:26 UTC

Becton Dickinson is trading lower in after-market hours, reversing an initial gain. No specific news was identified to explain this price movement.

10 aug 2026, 19:43 UTC

News

Becton Dickinson reports EPS of $3.23, exceeding estimates, and updates fiscal 2026 guidance, driving shares higher amid strong health care equipment sector gains.

7 aug 2026, 21:11 UTC

News

Citigroup maintained its Buy rating on Becton Dickinson and raised its price target to $204, contributing to the stock's higher after-market trading.

6 aug 2026, 23:01 UTC

Becton Dickinson and Co shares are higher in after-market hours, continuing a trend of three consecutive daily gains and remaining above the 20-day moving average.

Peer Vergelijking

Prijswijziging

Becton Dickinson and Co Prognose

Koersdoel

By TipRanks

6.97% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 193.3 USD  6.97%

Hoogste 210 USD

Laagste 175 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Becton Dickinson and Co - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

5

Buy

5

Hold

0

Sell

Sentiment

By Acuity

247 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.